Online edition zviazda.by

Country reports leading positions in vaccination coverage and organ transplantation, alongside more than 170,000 practising doctors.

The Emirates Drug Establishment (EDE) has approved a new therapeutic indication for RINVOQ (upadacitinib) to treat non-segmental vitiligo in adults and adolescents aged 12 years and older whose condition requires systemic therapy through medicines that circulate in the bloodstream, making it the first licensed oral treatment for this group of patients.